Session Description:

Introducing new breakthroughs in diabetes technology from Dexcom, the leader in trusted CGM performance. We invite you to join us to learn more about the two newest additions to the Dexcom portfolio: Dexcom G7 and Dexcom ONE. This program will review current data on the use of RT-CGM for people with type 1 and type 2 diabetes, revealing opportunities to improve care across the lifespan. In this session you will gain a deeper understanding of the performance and accuracy of the Dexcom G7 System in both adult and pediatric populations and hear more about the unique features that can improve the efficiency and effectiveness of clinical decision making. We will share our strategy to expand access to CGM technology and increase utilization with Dexcom ONE globally. Additionally, our experts will share their practical experience for incorporating both products into your practice.